Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC734622261;22262;22263 chr2:178722863;178722862;178722861chr2:179587590;179587589;179587588
N2AB702921310;21311;21312 chr2:178722863;178722862;178722861chr2:179587590;179587589;179587588
N2A610218529;18530;18531 chr2:178722863;178722862;178722861chr2:179587590;179587589;179587588
N2BNoneNone chr2:Nonechr2:None
Novex-1NoneNone chr2:Nonechr2:None
Novex-2NoneNone chr2:Nonechr2:None
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: V
  • RefSeq wild type transcript codon: GTT
  • RefSeq wild type template codon: CAA
  • Domain: Ig-58
  • Domain position: 24
  • Structural Position: 35
  • Q(SASA): 0.118
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
V/A rs1253051189 None 0.636 N 0.698 0.486 0.609565839933 gnomAD-3.1.2 1.31E-05 None None None None N None 4.83E-05 0 0 0 0 None 0 0 0 0 0
V/A rs1253051189 None 0.636 N 0.698 0.486 0.609565839933 gnomAD-4.0.0 2.47973E-06 None None None None N None 5.34131E-05 0 None 0 0 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
V/A 0.5839 likely_pathogenic 0.6856 pathogenic -1.954 Destabilizing 0.636 D 0.698 prob.neutral N 0.49866733 None None N
V/C 0.968 likely_pathogenic 0.9742 pathogenic -1.195 Destabilizing 0.998 D 0.791 deleterious None None None None N
V/D 0.9899 likely_pathogenic 0.9948 pathogenic -2.715 Highly Destabilizing 0.998 D 0.838 deleterious D 0.573924875 None None N
V/E 0.9676 likely_pathogenic 0.9818 pathogenic -2.423 Highly Destabilizing 0.681 D 0.576 neutral None None None None N
V/F 0.6157 likely_pathogenic 0.6756 pathogenic -1.098 Destabilizing 0.965 D 0.833 deleterious D 0.56475973 None None N
V/G 0.8039 likely_pathogenic 0.8734 pathogenic -2.543 Highly Destabilizing 0.99 D 0.836 deleterious D 0.573924875 None None N
V/H 0.992 likely_pathogenic 0.9951 pathogenic -2.496 Highly Destabilizing 1.0 D 0.84 deleterious None None None None N
V/I 0.0908 likely_benign 0.1042 benign -0.266 Destabilizing 0.005 N 0.257 neutral N 0.510516332 None None N
V/K 0.9811 likely_pathogenic 0.9884 pathogenic -1.407 Destabilizing 0.998 D 0.811 deleterious None None None None N
V/L 0.3022 likely_benign 0.383 ambiguous -0.266 Destabilizing 0.002 N 0.315 neutral D 0.547731348 None None N
V/M 0.4195 ambiguous 0.5116 ambiguous -0.374 Destabilizing 0.963 D 0.719 prob.delet. None None None None N
V/N 0.9771 likely_pathogenic 0.9869 pathogenic -1.965 Destabilizing 0.994 D 0.858 deleterious None None None None N
V/P 0.9839 likely_pathogenic 0.9895 pathogenic -0.807 Destabilizing 0.998 D 0.836 deleterious None None None None N
V/Q 0.9751 likely_pathogenic 0.9853 pathogenic -1.651 Destabilizing 0.997 D 0.836 deleterious None None None None N
V/R 0.9679 likely_pathogenic 0.9797 pathogenic -1.527 Destabilizing 0.999 D 0.858 deleterious None None None None N
V/S 0.9016 likely_pathogenic 0.9438 pathogenic -2.51 Highly Destabilizing 0.998 D 0.817 deleterious None None None None N
V/T 0.6787 likely_pathogenic 0.7697 pathogenic -2.064 Highly Destabilizing 0.986 D 0.735 prob.delet. None None None None N
V/W 0.988 likely_pathogenic 0.9929 pathogenic -1.712 Destabilizing 1.0 D 0.833 deleterious None None None None N
V/Y 0.9591 likely_pathogenic 0.9702 pathogenic -1.293 Destabilizing 1.0 D 0.814 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.